Arcadia Biosciences, Inc. (RKDA)

NCM – Real Time Price. Currency in USD

0.73

+0.06 (8.97%)

Market open: Aug 12, 2026, 2:12 PM EDT

0.68

+0.01 (1.69%)

Previous after-hours: Aug 11, 2026, 5:28 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-3M

-2M

-6M

Gross Profit

Operating expenses (excl. COGS)

-12M

-8M

-17M

Operating Income

-10M

-6M

-15M

Non-operating income, total

697K

Pretax income

-2M

-4M

-5M

-11M

Equity in earnings

Taxes

-8K

-14K

Non-controlling/minority interest

236K

After tax other income/expense

Net income before discontinued operations

-2M

-4M

-5M

-11M

Discontinued operations

-3M

-9M

-5M

Net income

-2M

-7M

-14M

-15M

Dilution adjustment

Preferred dividends

Arcadia Biosciences, Inc. (RKDA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Arcadia Biosciences, Inc. (RKDA)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Arcadia Biosciences, Inc. (RKDA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Arcadia Biosciences, Inc. (RKDA)

Income Statement (Annual)

Income Statement (Annual)